Domestic first AI-assisted R&D innovative drug Aipusiwei approved by drug regulator with conditional approval for market
Class 1 innovative drug Aipusiwei jointly developed by West Lake University and others approved for market, for treating COVID-19. This is the world's first small-molecule drug approved based on DEL technology, and also the first domestic AI-assisted developed original drug, taking only three and a half years from discovery to market.
Return to original text
A short introduction is retained here; the full text from the source website is not reposted. For specific wording and subsequent updates, please refer to the original article.
Open the original article on ITHome